This story came out of a conference I participated in yesterday put on by Markit. Creating a “tape” for OTC derivatives was a big topic of conversation, especially when it came time for CFTC Chairman Gensler to take questions. Excerpts from the story:
“They are looking at this like an exchange-traded market focused on the retail investor like in equities. It can’t be that way in OTCs because there’s not enough liquidity in any one product at any given time,” explained Kevin McPartland, senior analyst at TABB Group.
